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Identification of a Novel CD160þCD4þ
T-Lymphocyte Subset in the Skin: A Possible
Role for CD160 in Skin Inflammation
Sofia Abecassis1,2, Je´roˆme Giustiniani1, Nicolas Meyer1,2, Vale´rie Schiavon1, Nicolas Ortonne1,3,
Jose´ A. Campillo1, Martine Bagot1,2 and Armand Bensussan1
CD160 is a glycosylphosphatidylinositol-anchored cell surface molecule expressed by human circulating
cytotoxic lymphocytes that correspond to the majority of natural killer cell (NK) expressing CD56dim, TCRgd
lymphocytes, and to a minor CD8 T-cell subset. CD160 engagement by major histocompatibility complex class I
molecules triggers by itself both cytotoxic function and cytokine production in NK lymphocytes, whereas it
provides co-activating signals to TCR-induced proliferation in T CD8þ lymphocytes. In this study, we analyzed
by immunohistochemistry the phenotype of lymphocytes infiltrating normal skin and inflammatory skin lesions
of atopic dermatitis, contact dermatitis, and psoriasis. We identified a minor original subset of CD4þCD160þ T
cells infiltrating inflammatory lesions. We found that this lymphocyte subset localization is not restricted to the
skin, as we demonstrated that CD160 transcripts could be induced in IL-2 or IL-15-activated CD4þ peripheral
blood lymphocytes. Finally, we report that CD160 acts as a co-activator receptor for CD3-induced proliferation
of CD4þCD160þ T cells isolated from inflammatory skin lesions. Thus, we hypothesize that the unique
CD4þCD160þ lymphocyte subset plays a role in the pathogenesis of skin inflammation.
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INTRODUCTION
Infiltration of the skin by T cells is a major factor in the
pathogenesis of inflammatory skin diseases such as atopic
dermatitis (AD), contact dermatitis (CD), and psoriasis (PSO)
(Akiba et al., 2002; Gudjonsson et al., 2004; Leung et al.,
2004). AD and PSO are chronic inflammatory skin diseases
whose pathogenesis is not yet totally understood. A combina-
tion of factors has been incriminated in the pathogenesis of
AD, such as genetic background, environment triggering
factors, skin barrier dysfunction, and abnormal immunologic
responses (Leung et al., 2004). AD lesions are characterized
by a dermal and epidermal inflammatory infiltrate made
essentially of CD4-activated T cells (Lugovic et al., 2001). In
PSO, evidence indicates that keratinocyte proliferation,
which is the striking feature of the disease, results from
specific antigen recognition by T cells (Gudjonsson et al.,
2004). T cells also play a key role in the development of
CD by a mechanism of allergen sensitization (Lepoittevin
and Cribier, 1998). However, molecular pathways recruited
by T cells in skin inflammatory lesions are not yet totally
understood.
CD160 is a cell surface molecule expressed by human and
mouse circulating cytotoxic lymphocytes, as natural killer
cells (NK) CD56dimþCD16þ , most TCRgd T cells and
cytotoxic effector TCRab CD8T cells (Bensussan et al.,
1993; Maı¨za et al., 1993). It is also expressed by most
intestinal intraepithelial lymphocytes. It corresponds to a
multimeric glycosylphosphatidylinositol-anchored glycopro-
tein with a single Ig-like domain, weakly homologous to the
KIR2DL4 inhibitory receptors (Anumanthan et al., 1998).
Both human and mouse CD160 exhibit a broad specificity for
major histocompatibility complex class Ia and Ib molecules
(Agrawal et al., 1999; Maeda et al., 2005). The engagement
of CD160 by HLA-C is a triggering mechanism of circulating
NK-mediated cytotoxicity (Le Bouteiller et al., 2002) and
cytokines production (Barakonyi et al., 2004). On another
hand, CD160 is a co-receptor of TCR induced proliferation of
cytotoxic T cells (Nikolova et al., 2002; Rey et al., 2006). In
order to determine whether CD160þ T lymphocytes con-
tributed to the pathogenesis of skin inflammation, we studied
their presence among lymphocytes infiltrating inflammatory
lesions and whether CD160 triggering provides co-stimula-
tory effect to anti-CD3 mAb-induced proliferation.
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RESULTS
In situ immunohistochemical staining of inflammatory and
normal skin infiltrating cells revealed the presence of CD160þ
T lymphocytes
Single staining with anti-CD3, anti-CD4, anti-CD8, anti-
CD56, and anti-CD160 antibodies of four AD, six CD, and
one PSO lesion biopsy samples revealed in all cases a
marked dermal inflammatory infiltrate essentially made of
CD4þ T cells. A representative immunostaining obtained
with an AD skin biopsy is shown in Figure 1, right column.
Although few CD8þ T cells could be visualized (Figure 1d),
no CD56þ lymphocytes were detected in most dermal
inflammatory samples except for one AD sample in which
very few scattered CD56þ cells could be found (Figure 1h).
In contrast, in normal skin samples (Figure 1, left column),
only a few T cells infiltrated the dermis (Figure 1a), with a
peri-vascular distribution, and both CD4þ (Figure 1c) and
CD8þ T-cell (Figure 1e) subsets were equally represented.
Interestingly, we found that anti-CD160 antibodies stained a
variable proportion of cells within the inflammatory infiltrate
of AD (Figure 1j), CD, and PSO lesions (mean number of 16.6
CD160þ cells per high-power field (70 cells/mm2), range:
2–37 cells/high-power field (8–155 cells/mm2). Their presence
was not restricted to inflammatory skin lesions as CD160þ
cells were also present in the dermis of both normal skin
samples (mean number of 20 CD160þ cells per high-power
field (84 cells/mm2), range: 15.5–24.3 cells per high-power
field (65–102/mm2) (Figure 1i). Further, double immunohis-
tochemical staining with anti-CD3, anti-CD4, and anti-
CD160 mAbs performed with two AD, two CD and one
PSO lesions samples revealed the presence of CD160þ
CD3þ and CD160þCD4þ cells within the dermal inflam-
matory infiltrate (Figure 2a and b for AD and PSO lesions,
respectively), indicating the skin localization of a T-lympho-
cyte subset expressing CD160 molecules.
CD160 messenger RNA (mRNA) transcript is isolated from
inflammatory and normal skin samples as well from peripheral
blood (PB)-CD4þ cultured ex vivo with cytokines
In order to further demonstrate that the anti-CD160 mAb was
effectively reactive with CD160 molecules expressed by T
lymphocytes in the skin as evidenced by immunohistochem-
ical staining, we performed RT-PCR analysis using CD160-
specific primers on two AD and two healthy skin samples and
found that CD160 mRNA transcripts were present in all tested
skin samples as compared to PB-NK cells (Figure 3a). Control
purified PB-CD4þ were negative for CD160 mRNA. Next,
CD160 transcripts were isolated from both healthy and AD
skin for sequencing. The results clearly established that the
PCR products corresponded to CD160 mRNA as the amino-
acid sequence alignment of healthy and AD CD160 proteins
showed that they were identical to the CD160 sequence
already described. Interestingly, CD160 sequencing in one
AD skin biopsy revealed a novel allelic form with two
substituted residues that was also obtained in one normal
individual (Figure 3b). Next, as most CD160þ PB lympho-
cytes correspond to subsets of NK, T CD8þ , and TCRgdþ
lymphocytes, it was important to assess whether PB-CD4þ
lymphocytes could be induced to transcribe CD160 under
the presence of proinflammatory cytokines. We found that
whereas CD160 mRNA transcripts were not detected in
freshly isolated PB-CD4þ (Figure 4, lane 1) nor after 6 days of
culture with IL-4 (Figure 4, lane 2), they could be detected
when these cells were cultured during 6 days in the presence
of IL-2 alone (Figure 4, lane 3), IL-2, þ IL-4 (Figure 4, lane 4),
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Figure 1. In situ phenotype of inflammatory and normal skin cellular
infiltrates: detection of a CD160þ cell subset. Phenotype of cellular
infiltrates of the skin established by immunohistochemistry ( 100) on AD
skin (right column) and healthy skin (left column). In normal skin, there was a
minor infiltrate of CD3þ (a), CD4þ (c) and CD8þ T cells (e). In AD skin, we
found a marked dermal infiltrate made of CD3þ lymphocytes (b), mainly
CD4þ T cells (d) accompanied by CD8þ cells (f). There were no NK cells, as
CD56 stained only small nervous fibres of the dermis (g and h indicated by
arrow heads). CD160þ cells were present both in the inflammatory infiltrate
(j) and among resident cells of normal skin (i). Positively stained cells are
indicated with arrows. Bar¼ 0.25 mm.
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or IL-15 (Figure 4, lane 5). These results were obtained with
several other healthy donors, (data not shown), demonstrating
that CD160 mRNA expression is induced or increased in
normal individuals’ PB-CD4þ lymphocytes by proinflamma-
tory cytokines (Figure 4), and thus indicating that CD160
expression is not a characteristic of CD4þ skin lymphocytes
but is rather a characteristic of proinflammatory cytokine
activated CD4þ lymphocytes, as recently reported in mice
(Maeda et al., 2005).
CD160 is expressed and is functional in CD4þ lymphocytes
isolated from inflammatory skin
To study the function of CD160 expressed by CD4þ
lymphocytes isolated from inflammatory skin, biopsy speci-
mens from 3 AD (AD1, AD2, and AD3), 2 CD (CD1 and
CD2) and 1 PSO were expanded in culture medium
supplemented with cytokines (IL-2 and IL-4) for 1 week.
The phenotypic results presented in Table 1 indicated that the
growing cells consisted almost exclusively of CD3þ T cells
(95–100%), with a vast majority of CD4þ T cells (64–100%)
except for the PSO sample (24% CD4þ ). CD160þ cells
were present in lower proportions than those found in situ by
immunochemistry analysis on frozen samples obtained
concomitantly for the same patients (Table 1). This is not
surprising as biopsy samples are cultured in the presence of
IL-2 and Il-4, which enabled cell migration out from the skin
and cell proliferation, and that we have demonstrated with
TCRgd T-cell clones (Nikolova et al., 2002) and with PB-NK
lymphocytes (Le Bouteiller et al., 2002) that surface expres-
sion of CD160 is down-regulated by IL-2, whereas CD160
transcripts are still highly detectable (Giustiniani et al.,
in press). Nevertheless, cultured lymphocytes from AD3
(Figure 5a) CD1, CD2, and PSO skin biopsies still expressed
detectable surface expression of CD160 on CD4þ cells. A
representative CD4 and CD160 double staining result
obtained with AD3 cells is shown (Figure 5b). To study the
function of CD160 expressed on these cultured CD4þ skin
lymphocytes, we performed proliferative assays of AD3 cells
with anti-CD3 mAb in the presence or absence of anti-
CD160 mAb. Noted, CD160 was mostly expressed by CD4þ
and not by CD4 cells obtained from AD3 (Figure 5b). We
observed a significant increase in the CD3-induced prolifera-
tion in the presence of anti-CD160 mAb as compared to
isotype-matched control mAb (Figure 5c). Thus, these results
obtained with CD4þ skin lymphocytes confirm previous
reports that revealed that CD160 engagement triggers
co-activator signals to CD4 T Lymphocyte proliferation
induced by anti-CD3 mAb or HIV peptides (Nikolova et al.,
2002, 2005). Also in agreement with previous results the
a b
Figure 2. Presence of CD160þ T-cells and CD160þCD4þ cells within the
inflammatory skin infiltrates. Demonstrated by immunochemistry double
staining ( 100). (a) CD160þ T cells infiltrating the dermis in AD. CD3 is
stained in red and CD160 in brown. CD160þ T cells are indicated with
arrows. (b) CD160þCD4þ cells in the papillary dermis of a PSO lesion are
indicated with arrows. CD4 is stained in red and CD160 in brown.
Bar¼0.1 mm.
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Figure 3. Detection of CD160 mRNA in healthy and inflammatory skin
samples. (a) CD160 mRNA was identified by PCR analysis after mRNA
extraction from frozen samples of healthy skin (HS1 and HS2) and AD lesions
(AD1 and AD2). Positive and negative controls consisted respectively of
PB-NK and CD4þ T-cells from a healthy subject. Detection of b-actin mRNA
also served as a positive control for each experiment. (b) CD160 mRNA was
identified by cDNA sequence analysis.
Table 1. Phenotypic analysis of ex vivo cultured
lymphocytes isolated from inflammatory skin biopsies
CD3 (%) CD4 (%) CD160 (%)
AD1 96 64 o1
AD2 98 97 o1
AD3 Not tested 93 77
CD1 Not tested 90 15
CD2 100 100 9
PSO NT 24 9
AD, atopic dermatitis; CD, contact dermatitis; PSO, psoriasis.
Skin biopsies were obtained from patients with atopic dermatitis (AD1,
AD2, and AD3), contact dermatitis (CD1 and CD2), and psoriasis (PSO).
CD160
-actin
1     2      3      4      5
Figure 4. Regulation of the CD160 expression by CD4þ T cells by IL2 and
IL15 and not by IL-4. The expression of CD160 mRNA transcript in PB-CD4þ
is induced by IL-2 and IL-15, but not IL-4. CD160 mRNA transcript was not
detected in freshly isolated (1) PB-CD4þ nor after 6 days of culture in the
presence of (2) IL-4, however it could be detected in PB-CD4þ cultured
during 6 days in the presence of (3) IL-2, (4) IL-2 þ IL-4, or (5) IL-15.
Detection of b-actin mRNA served as positive control for each experiment.
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stimulation of CD160 alone by anti-CD160 mAb did not
induce cell proliferation (data not shown).
DISCUSSION
In this study, we identified a subset of CD160þ T cells
infiltrating inflammatory skin lesions of AD, PSO, and CD, as
shown by immunohistochemistry, tissue mRNA extraction,
and complementary DNA (cDNA) sequence analysis results.
Interestingly, we detected a particular minor subset of
CD160þCD4þ T cells in inflammatory skin lesions, as
shown by in situ immunohistochemistry experiments.
CD160þ cells were also identified within the cellular
infiltrate of normal skin. A low-density lymphocyte infiltrate
is usually present in the dermis of normal skin. It is mostly
composed of activated CD4 and CD8 T cells in similar
proportions, expressing HLA-DR, and the a chain-IL-2
receptor (CD25) (Bos et al., 1987), and these cells are
thought to play a role of immune surveillance of the skin
(Streilein, 1989).
There is evidence for a role of cytotoxic T cells in the
development of lesions in AD, PSO, and CD. Both CD4þ and
CD8þ T lymphocytes expressing granzyme B and perforin
are present within the inflammatory infiltrate of AD and PSO
lesions (Yawalkar et al., 2001). Furthermore, Fas-induced
keratinocyte apoptosis mediated by skin infiltrating lympho-
cytes is considered as a major event in the development of
AD lesions (Trautmann et al., 2000). Skin inflammation
during CD depends on the early recruitment of CD8 cytotoxic
T cells inducing keratinocyte apoptosis (Akiba et al., 2002).
We previously reported that BY55/CD160 receptor expres-
sion is restricted to functional circulating cytotoxic lympho-
cytes that are mostly NK lymphocytes and a minor subset of
CD8þ T cells (Bensussan et al., 1994). The engagement of
CD160 triggers NK-mediated cytotoxicity (Le Bouteiller et al.,
2002) and contributes to the enhancement of T-cell
proliferation induced by anti-CD3 mAb stimulation (Nikolo-
va et al., 2002) and to the enhancement of anti-CD3 mAb
redirected cytotoxicity (Rey et al., 2006). As we found that
CD160 is expressed by a subset of CD4þ T cells in
inflammatory skin infiltrates, it suggests that its engagement
with the physiological ligands (major histocompatibility
complex class I molecules) provides in situ co-stimulatory
signals for CD4þ T-cell proliferation, proinflammatory
cytokine production and for killer cell activities. Cytotoxicity
was initially attributed to NK and CD8þ T cells, but it is now
recognized that CD4þ T cells can also exhibit cytotoxic
activity using granzyme B/perforin or Fas/Fas-L-mediated
pathways (Vergelli et al., 1997). However, triggering me-
chanisms of CD4þ T-cell-mediated cytotoxicity are still not
completely understood. Here, using ex vivo cultured T
lymphocytes infiltrating inflammatory skin lesions we de-
monstrated that the engagement of CD160 enhances the
CD4þCD160þ cells proliferation induced by the stimulation
of CD3. In addition, we observed by flow cytometry analysis
that these cells co-expressed granzyme B (data not shown).
Thus, for the first time we report a unique lymphocyte
population with a CD4þCD160þ phenotype that could be
isolated and cultured from inflammatory skin lesions. Further
studies are needed for evidencing that engagement of CD160
could be part of the triggering signal leading to CD4þ
cytotoxicity, as we recently reported for the circulat-
ing CD8þ lymphocyte population expressing CD160 (Rey
et al., 2006).
Interestingly, we demonstrated that IL-2 or IL-15 induces
CD160 mRNA expression in PB-CD4þ T-cells, indicating
that CD160þCD4þ cells is not a characteristic of skin-
derived lymphocytes. On another hand, we have previously
demonstrated that IL-2 downregulates the membrane expres-
sion of CD160 by peripheral circulating NK lymphocytes
(Maı¨za et al., 1993; Le Bouteiller et al., 2002) and T-cell
clones (Nikolova et al., 2002). Thus, IL-2 expressed in
inflammatory skin lesions of AD (Grewe et al., 1995), PSO
(Bata-Csorgo et al., 1995), and CD (Lepoittevin and Cribier,
1998) could regulate in situ the expression of CD160 by
CD4þ T cells infiltrating the lesions.
In conclusion, our results suggest that CD160 expression
on infiltrating T lymphocytes plays a role in the development
of skin inflammation, but its exact function in situ remains to
be elucidated by further experiments.
MATERIALS AND METHODS
Subjects and skin specimens
After obtaining written informed consent and institutional approval
of experiments, we performed punch biopsies of 3–4 mm from
lesions of 11 subjects affected with inflammatory skin conditions
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Figure 5. Expression and Function of CD160 on lymphocytes extracted
from CD. (a) In vitro identification of the CD160þ CD4þ T-cell subset. Flow
cytometry phenotype analysis of cells obtained from AD3 AD biopsy after
cell expansion in vitro showed that CD160 was mostly expressed by CD4þ
lymphocytes (b) CD160 acts as a co-receptor of CD3 induced proliferation of
ex vivo cultured CD4þCD160þ T cells (AD3). Proliferation assay showing
increased CD3-induced proliferation after CD160 stimulation as compared to
controls (isotype-matched mAb IgM and goat anti-mouse antiboby (GAM)).
BY55 is IgM anti-CD160 mAb.
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(four women and seven men, mean age of 47 years, range: 15–77
years): four AD diagnosed according to Hanifin and Rajka (1980)
criteria, six CD and one PSO. In addition, two normal skin samples
were obtained from abdominal and breast plastic surgery (two
women of 39 and 60 years, mean age of 49.5 years). The Declaration
of Helsinki Principles were followed. Skin samples were snap-frozen
without tissue embedding medium using liquid nitrogen and stored
at 801C. These samples were used for immunohistochemistry, and
immunoflurescence staining, and for tissue RNA extraction. A
second concomitant sample was obtained from four of these patients
(two patients with AD (AD1 and AD2) and two patients with CD
(CD1 and CD2)) and from two additional patients (37-year-old male
with AD (AD3) and a 36-year-old female with PSO) for ex vivo
cell cultures.
Lymphocytes isolation and cultures
As previously described (Bang et al., 2001), inflammatory skin
samples from three patients with AD (AD1, AD2, and AD3), two
patients with CD (CD1 and CD2), and one patient with PSO were
placed in a 24-well plate with culture medium consisting of
Rosewell Park Memorial Institute 1640 (Gibco, Paisley, UK), 10%
heat-inactivated human serum sodium pyruvate (1 mmol per liter),
L-glutamine 2 mmol per liter), streptomycin (100 mg per ml), penicil-
lin (100 U per ml, fungizone (1mg per ml), IL-2 (200 U per ml; gifted
from Sanofi-Aventis, Labege, France) and IL-4 (50 ng per ml; Pepro-
Tech, Levallois-Perret, France), at 371C, which enabled after 1 week
cell migration out from the skin, followed by marked proliferation.
These cells were then used for phenotypical studies by flow
cytometry and proliferation assays.
Peripheral blood CD4þ (PB-CD4þ ) T cells were obtained by
positive selection from freshly isolated peripheral blood mono-
nuclear cells from a healthy donor using magnetic bead sorting
(MAC/Miltenyl Biotec, Bergisch Gladbach, Germany). Freshly sorted
PB-CD4þ were separated in different groups of 5 106 cells each
for 6 days of culture in medium containing different cytokines
including 200 U per ml IL-2 alone or with 50 ng per ml IL-4,
50 ng per ml IL-4 alone, or 10 ng/ml IL-15 alone (PeproTech).
Immunohistochemistry
Single staining for CD3, CD4, CD8, CD56, and CD160 was
performed using the avidin–biotin complex/alkaline phosphatase
method. Primary monoclonal antibodies anti-CD3 (IgG), anti-CD4
(IgG), and anti-CD8 (IgG) were purchased from Dako, Copenhagen,
Denmark, and used diluted 1/50. Anti-CD56 was obtained from
Coulter/Beckman, Marseille, France, and used diluted 1/50. Anti-
CD160 was produced in our laboratory and used diluted 1/20.
Substitution of the primary antibody with isotype-matched Ig served
as negative control. After fixation for 5 minutes with acetone and
brief air drying, slides were incubated for 10 minutes with blocking
serum (Vectastain/Vector, Burlingame, CA), then for 1 hour with the
primary mAb at room temperature followed by a biotinylated
secondary anti-mouse antibody (Vectastain/Vector) and thereafter
with avidin-alkaline phosphatase (Vectastain/Vector). Finally, all
sections were developed in naphtol-fast red (Sigma-Aldrich, Saint
Quentin Fallavier, France) and counterstained with hematoxylin.
Double staining was performed in inflammatory skin samples by
combining CD3 or CD4 staining using anti-IgG conjugated with
alkaline phosphatase with CD160 staining using the avidin–biotin
complex/peroxydase method. After fixation for 5 minutes with
acetone and brief air drying, slides were incubated for 10 minutes
with blocking serum (Vectastain/Vector), then for 1 hour with the
primary mouse mAb (anti-CD3 or anti-CD4, IgG) at room
temperature, followed by a secondary anti-IgG antibody conjugated
with alkaline phosphatase (Sigma-Aldrich). Slides were developed in
naphtol-fast red (Sigma-Aldrich). Slides were then incubated with
BSA for 20 minutes in order to block any possible cross-reaction.
Endogenous peroxydase was quenched with peroxydase inhibitor
(Dako). Afterwards, slides were incubated with anti-CD160 IgM
mouse mAb, followed by a biotinylated secondary anti-mouse IgM
antibody (Vectastain/Vector) and thereafter with avidin-peroxidase
(Vectastain/Vector). Slides were developed in 30-30-diaminobenzi-
dine (Vectastain/Vector) and counterstained with hematoxylin.
Tissue RNA extraction, cell RNA extraction, RT-PCR, and cDNA
sequence analysis
RNA was extracted from frozen skin samples of two AD lesions and
two normal skin samples. Ten cryostat sections of 50mm from each
frozen sample were homogenized in TRIzol reagent (Invitrogen,
Cergy Pontoise, France) and RNA was extracted under conditions
recommended by the manufacturer. Similar RNA extractions were
performed from CD4þ T cells obtained by positive selection from
freshly isolated peripheral blood mononuclear cells from a healthy
donor and from the same CD4þ T cells further cultured with
cytokines. For PCR amplification of the CD160 transcript, 2–5mg of
RNA were reverse transcribed into cDNA (BD Biosciences, Palo
Alto, CA). One microgram of cDNA was used for PCR analysis
(Invitrogen, Carlsbad, CA) with synthetic oligonucleotide primers
(forward: TGCAGGATGCTGTTGGAACCC, reverse: CCTGTGCCCT
GTTGCATTCTTC). After an initial hot start, amplification of CD160
consisted of 35 cycles of 30 seconds at 951C, 20 seconds at 601C,
and 1 minute at 721C. The following controls were used: PB-CD4þ
cDNA from a healthy donor as a negative control, circulating NK
cDNA from a healthy donor as a positive control. PCR products were
separated by electrophoresis in 5% agarose gel, purified (Qiaex II/
Qiagen GmbH, Germany), sequenced with the same oligonucleo-
tide primers and analyzed with an automated fluorescent DNA
sequencer (ABI Prism/Applied Biosystem, Foster City, CA).
Flow cytometry analysis
Phenotype of cultured cells obtained from biopsy samples of three
AD (AD1, AD2, and AD3), two CD (CD1 and CD2), and one PSO
were analyzed by flow cytometry. Expression of cell surface
molecules was determined by direct (anti-CD3, anti-CD4, anti-
CD8) or indirect (anti-CD160) labeling. Isotype-matched antibodies
were used as negative controls. All antibodies were purchased from
coulter/Beckman. Phycoerythrin-goat-anti mouse IgM was used as
secondary reagent for anti-CD160 antibodies. Samples were labeled
as previously reported (Poszepczynska-Guigne et al., 2004) and flow
cytometry analysis was carried out using the EPICS XL (Beckman-
Coulter, Miami, FL).
Proliferation assays
T CD4þ cells obtained from a biopsy sample of AD (AD3) after an in
vitro expansion with IL-2 and IL-4 were used in proliferation assays.
After extensive washing the cells were plated at 50 103 cells/well
in 96-well microtiter plates (Flow laboratories, McLean, VA),
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previously coated with goat-anti-mouse antibody, in the presence of
anti-CD160 and anti-CD3 mAbs or in the presence of isotype-
matched control and anti-CD3 mAbs as previously reported
(Nikolova, Int Immunol). Anti-CD3 mAb was used at two different
concentrations. Each culture was performed in triplicate. Cells were
cultured 72 hours, followed by an 8 hours pulse with 1 m Ci
[3H]thymidine. Radioactive incorporation was measured in a liquid
scintillation counter (Topcount, Packard, Meriden, CT). The experi-
ment was performed twice.
Statistical analysis
Data were analyzed using GraphPad Prism program. Experimental
differences over the controls were analysed by two-tailed unpaired
t-test. Data were expressed as mean7SD, and significant differences
were set at Po0.05. In all cases at least three independent
experiments were conducted.
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